Pharvaris HAE drug hits 83% attack rate cut in phase 3 trial
Go back to Pharvaris HAE drug hits 83% attack rate cut in phase 3 trial| (NASDAQ: PHVS) | Delayed: 32.93 -0.06 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.99 | 52 Week High | $ | |||
| Open | $33.08 | 52 Week Low | $ | |||
| Day High | $33.62 | P/E | N/A | |||
| Day Low | $32.14 | EPS | $ | |||
| Volume | 145,200 | |||||
